<DOC>
	<DOCNO>NCT00519389</DOCNO>
	<brief_summary>This Phase I/IIa randomize , double-blind , placebo-controlled study evaluate safety , reactogenicity , immunogenicity 3 potency ( dosage ) H5N1 VLP vaccine placebo healthy adult 18 40 year age .</brief_summary>
	<brief_title>Safety , Reactogenicity Immunogenicity H5N1 VLP</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female 18 40 year age time vaccination . 2 . Subjects investigator believe comply requirement protocol ( e.g. , return followup visit completion data collection tool ) . 3 . Available telephone . 4 . Free obvious health problem establish medical history clinical examination enter study . 5 . If subject childbearing potential , must abstinent use adequate contraceptive precaution ( e.g. , intrauterine contraceptive device ; oral contraceptive equivalent hormonal contraception ) 30 day prior vaccination . She must also negative pregnancy test study entry must agree continue precaution two month completion vaccination . 6 . Must provide write , informed consent . 1 . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede administration study vaccine , plan use study period . 2 . Has receive license vaccine within 4 week prior enrollment study . 3 . Has receive influenza vaccine within prior 12 month period . 4 . Has receive investigational vaccine design protection avian influenza . 5 . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior administration study vaccine . The use inhale nasal steroid permit . 6 . Any medically diagnose suspect immunodeficient condition base medical history physical examination . 7 . Administration immunoglobulins and/or blood product within three month precede administration study vaccine study . 8 . Acute disease time enrollment . Acute disease define presence moderate severe illness without fever ≥ 100.5º F. 9 . Acute clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . 10 . Major congenital defect serious chronic illness . 11 . History neurological disorder seizure , exception febrile seizures childhood .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>